Estrogen Status and Heredity Are Major Determinants of Premenopausal Bone Mass

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1992 Dec 1

PMID 1469098

Citations 38

Authors

R Armamento-Villareal

D T Villareal

L V Avioli

R Civitelli

Affiliations

Soon will be listed here.

Abstract

To analyze their relative effects on premenopausal bone mass, we have studied the impact of lifelong estrogen exposure, assessed by an estrogen score (ES; computed on age at menarche, average length of menstrual cycles since menarche, and use of birth control pills), heredity, and some environmental factors on vertebral bone density (VBD), of 63 premenopausal women (age, 19-40 yr). Compared with women with normal bone density (Z score > -1), subjects with low VBD (Z score < -1) had significantly lower ES (15.1 +/- 3.9 vs. 18.7 +/- 2.4, P = 0.001), higher age at menarche (13.8 +/- 1.7 vs. 12.6 +/- 1.4 yr, P = 0.005), and lower serum estradiol (46.9 +/- 37 vs. 86.6 +/- 57 pg/ml, P = 0.023) and estrone levels (107.4 +/- 60 vs. 178.8 +/- 9.0 pg/ml, P = 0.05). Likewise, women in the lowest quartile for VBD had significantly lower ES (15.3 +/- 4.5 vs. 18.1 +/- 2.7, P = 0.006) and higher age at menarche (13.9 +/- 1.9 vs. 12.8 +/- .4, P = 0.02) than those in the upper three quartiles. A higher proportion of subjects with irregular menses (52 vs. 23%, P = 0.03) and a positive family history of osteoporosis (86 vs. 61%, P = 0.04) was found in the low VBD group compared with subjects with normal VBD. VBD correlated positively with ES (r = 0.44, P = < 0.001) and negatively with age at menarche (r = -0.30, P = 0.03) by simple linear regression, whereas no correlation was found between VBD and age, body mass index, parity, lactation, physical activity, sunlight exposure, and dietary calcium and vitamin D intakes. The correlation between VBD and ES improved after correcting for the effect of all the other variables by partial correlation analysis (Pearson partial r = 0.57, P = < 0.01), which also disclosed a significant contribution of dietary calcium to VBD. However, ES was the only significant independent determinant of VBD, by stepwise multiple regression analysis (R2 = 0.24). Therefore, premenopausal estrogen exposure, and possibly genetic predisposition, rather than environmental factors, are the major determinants for the development of peak bone mass before menopause.

Citing Articles

A Prospective Evaluation of Serum Vitamin D (1, 25(OH) D) and Endogenous Sex Hormone Levels in Colorectal Cancer Patients.

Razak S, Alam I, Afsar T, Abulmeaty M, Almajwal A, Jahan S Front Oncol. 2019; 9:468.

PMID: 31214508 PMC: 6558010. DOI: 10.3389/fonc.2019.00468.

Retinoic acid signaling in ovarian folliculogenesis and steroidogenesis.

Damdimopoulou P, Chiang C, Flaws J Reprod Toxicol. 2019; 87:32-41.

PMID: 31059772 PMC: 6613987. DOI: 10.1016/j.reprotox.2019.04.007.

Poor sleep quality and later sleep timing are risk factors for osteopenia and sarcopenia in middle-aged men and women: The NEO study.

Lucassen E, de Mutsert R, le Cessie S, Appelman-Dijkstra N, Rosendaal F, van Heemst D PLoS One. 2017; 12(5):e0176685.

PMID: 28459884 PMC: 5411054. DOI: 10.1371/journal.pone.0176685.

Equol inhibits growth, induces atresia, and inhibits steroidogenesis of mouse antral follicles in vitro.

Mahalingam S, Gao L, Gonnering M, Helferich W, Flaws J Toxicol Appl Pharmacol. 2016; 295:47-55.

PMID: 26876617 PMC: 4779678. DOI: 10.1016/j.taap.2016.02.009.

Genistein exposure inhibits growth and alters steroidogenesis in adult mouse antral follicles.

Patel S, Peretz J, Pan Y, Helferich W, Flaws J Toxicol Appl Pharmacol. 2016; 293:53-62.

PMID: 26792615 PMC: 4744102. DOI: 10.1016/j.taap.2015.12.026.

References

Watts N, Harris S, Genant H, Wasnich R, Miller P, Jackson R . Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med. 1990; 323(2):73-9. DOI: 10.1056/NEJM199007123230201. View

Gruber H, Ivey J, Baylink D, Matthews M, Nelp W, Sisom K . Long-term calcitonin therapy in postmenopausal osteoporosis. Metabolism. 1984; 33(4):295-303. DOI: 10.1016/0026-0495(84)90187-2. View

Sowers M, Shapiro B, Gilbraith M, Jannausch M . Health and hormonal characteristics of premenopausal women with lower bone mass. Calcif Tissue Int. 1990; 47(3):130-5. DOI: 10.1007/BF02555976. View

Ott S . Attainment of peak bone mass. J Clin Endocrinol Metab. 1990; 71(5):1082A-1082C. DOI: 10.1210/jcem-71-5-1082. View

Dhuper S, Warren M, Brooks-Gunn J, Fox R . Effects of hormonal status on bone density in adolescent girls. J Clin Endocrinol Metab. 1990; 71(5):1083-8. DOI: 10.1210/jcem-71-5-1083. View

Matkovic V, Fontana D, Tominac C, Goel P, Chesnut 3rd C . Factors that influence peak bone mass formation: a study of calcium balance and the inheritance of bone mass in adolescent females. Am J Clin Nutr. 1990; 52(5):878-88. DOI: 10.1093/ajcn/52.5.878. View

Pacifici R, Rupich R, Avioli L . Vertebral cortical bone mass measurement by a new quantitative computer tomography method: correlations with vertebral trabecular bone measurements. Calcif Tissue Int. 1990; 47(4):215-20. DOI: 10.1007/BF02555922. View

Baran D, Sorensen A, Grimes J, Lew R, Karellas A, Johnson B . Dietary modification with dairy products for preventing vertebral bone loss in premenopausal women: a three-year prospective study. J Clin Endocrinol Metab. 1990; 70(1):264-70. DOI: 10.1210/jcem-70-1-264. View

Drinkwater B, Bruemner B, Chesnut 3rd C . Menstrual history as a determinant of current bone density in young athletes. JAMA. 1990; 263(4):545-8. View

10.

Davee A, Rosen C, Adler R . Exercise patterns and trabecular bone density in college women. J Bone Miner Res. 1990; 5(3):245-50. DOI: 10.1002/jbmr.5650050307. View

11.

Tylavsky F, Bortz A, Hancock R, Anderson J . Familial resemblance of radial bone mass between premenopausal mothers and their college-age daughters. Calcif Tissue Int. 1989; 45(5):265-72. DOI: 10.1007/BF02556017. View

12.

Steinberg K, DePuey E, Miller D, SGOUTAS D, Coralli C, Phillips D . Sex steroids and bone density in premenopausal and perimenopausal women. J Clin Endocrinol Metab. 1989; 69(3):533-9. DOI: 10.1210/jcem-69-3-533. View

13.

Block J, Smith R, Glueer C, Steiger P, Ettinger B, Genant H . Models of spinal trabecular bone loss as determined by quantitative computed tomography. J Bone Miner Res. 1989; 4(2):249-57. DOI: 10.1002/jbmr.5650040218. View

14.

Rosenthal D, Mayo-Smith W, Hayes C, Khurana J, Biller B, Neer R . Age and bone mass in premenopausal women. J Bone Miner Res. 1989; 4(4):533-8. DOI: 10.1002/jbmr.5650040412. View

15.

Seeman E, Hopper J, Bach L, Cooper M, Parkinson E, McKay J . Reduced bone mass in daughters of women with osteoporosis. N Engl J Med. 1989; 320(9):554-8. DOI: 10.1056/NEJM198903023200903. View

16.

Lloyd T, Buchanan J, Ursino G, Myers C, Woodward G, Halbert D . Long-term oral contraceptive use does not affect trabecular bone density. Am J Obstet Gynecol. 1989; 160(2):402-4. DOI: 10.1016/0002-9378(89)90457-2. View

17.

Buchanan J, Myers C, Lloyd T, Leuenberger P, Demers L . Determinants of peak trabecular bone density in women: the role of androgens, estrogen, and exercise. J Bone Miner Res. 1988; 3(6):673-80. DOI: 10.1002/jbmr.5650030613. View

18.

Dalsky G, Stocke K, Ehsani A, Slatopolsky E, Lee W, BIRGE Jr S . Weight-bearing exercise training and lumbar bone mineral content in postmenopausal women. Ann Intern Med. 1988; 108(6):824-8. DOI: 10.7326/0003-4819-108-6-824. View

19.

Liel Y, Edwards J, Shary J, Spicer K, Gordon L, Bell N . The effects of race and body habitus on bone mineral density of the radius, hip, and spine in premenopausal women. J Clin Endocrinol Metab. 1988; 66(6):1247-50. DOI: 10.1210/jcem-66-6-1247. View

20.

HRESHCHYSHYN M, Hopkins A, Zylstra S, Anbar M . Associations of parity, breast-feeding, and birth control pills with lumbar spine and femoral neck bone densities. Am J Obstet Gynecol. 1988; 159(2):318-22. DOI: 10.1016/s0002-9378(88)80075-9. View